Orient Technologies (NSE: ORIENTTECH) Q3 FY26 results: Why short-term margin pain may be the price of securing long-cycle government and services revenue
Read More 6 minute read Healthcare Industry News PACS Group (NYSE: PACS) stock soars 149% in five days as restatement clears audit cloud and Q3 earnings beat forecasts PACS Group stock surges 149 percent in five days after restatement and Q3 earnings beat. Find out what’s driving investor confidence and what to watch next. bySrinathNovember 20, 2025